This is Me Trying | GameChangers

The TAILOR-PCI Trial evaluates the outcomes between genotype-guided P2Y12 inhibitor selection versus conventional prescribing on ischemic outcomes. Listen to Geoff Wall and guest, Jake Galdo, discuss the role of pharmacogenomics in patient care.

Additional Resource/Reference:

 

https://jamanetwork.com/journals/jama/article-abstract/2769725 

This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!

See omnystudio.com/listener for privacy information.

Leave a Comment

Stay confident and competent.

Join over 100,000 Pharmacists & Technicians in our Pharmacy Community!

Experience the difference with CEimpact Education

Let's have a chat

0